Persistence with teriparatide in patients with osteoporosis: the UK experience

被引：0
|
作者：
N. K. Arden
S. Earl
D. J. Fisher
C. Cooper
S. Carruthers
M. Goater
机构：
[1] Southampton General Hospital,MRC Epidemiology Resource Centre, University of Southampton
[2] Southampton General Hospital,Department of Rheumatology
[3] Healthcare at Home,undefined
[4] Eli Lilly and Company,undefined
来源：
Osteoporosis International | 2006年 / 17卷
关键词：
Adverse events; Compliance; Osteoporosis; Persistence; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1626 / 1629
页数：3
相关论文
共 50 条
  • [1] Persistence with teriparatide in patients with osteoporosis: the UK experience
    Arden, N. K.
    Earl, S.
    Fisher, D. J.
    Cooper, C.
    Carruthers, S.
    Goater, M.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 (11) : 1626 - 1629
  • [2] Persistence with teriparatide in men with osteoporosis: The UK experience
    Abhishek, Abhishek
    Pande, Ira
    RHEUMATOLOGY, 2008, 47 : II173 - II173
  • [3] TERIPARATIDE IN PATIENTS WITH OSTEOPOROSIS - OUR EXPERIENCE
    Nikolic, Aleksandra Karadzov
    Pilipovic, Nada
    Brankovic, Slobodan
    Novkovic, Snezana
    Basaric, Milica
    Pasalic, Katarina Simic
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S297 - S297
  • [4] Adherence and persistence in patients with severe osteoporosis treated with teriparatide
    Ziller, V.
    Zimmermann, S. P.
    Kalder, M.
    Ziller, M.
    Sekar-Pektas, B.
    Hellmeyer, L.
    Hadji, P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (03) : 675 - 681
  • [5] Improvement of the persistence with teriparatide in postmenopausal osteoporosis: The French experience of an education program
    Briot, K.
    Ravaud, P.
    Liu-Leage, S.
    Roux, C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S213 - S213
  • [6] Improvement of the persistence with teriparatide in postmenopausal osteoporosis:: The french experience of an education program
    Briot, K.
    Ravaud, P.
    Liu-Leage, S.
    Roux, C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S508 - S508
  • [7] OUR EXPERIENCE WITH TERIPARATIDE (FORSTEO) IN PATIENTS WITH SEVERE OSTEOPOROSIS
    Popova, V. P.
    Popova, M. P. Gebeva
    Vazhev, Z. V.
    Ronchev, Y. R.
    Kraev, K. K.
    Batalov, A. B.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S231 - S232
  • [8] PERSISTENCE WITH TERIPARATIDE (LY333334) IN OSTEOPOROSIS : THE EXPERIENCE OF THE RHEUMATOLOGICAL DEPARTMENT OF THE HOSPITAL OF PARMA
    Di Donato, E.
    Magalini, F.
    Ariani, A.
    Becciolini, A.
    Casella, M.
    Santilli, D.
    Riva, M.
    Mozzani, F.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S487 - S487
  • [9] Teriparatide in men: persistence and geographical variation in the UK
    A. Abhishek
    I. Pande
    Osteoporosis International, 2009, 20 : 1453 - 1454
  • [10] Persistence with teriparatide in patients with severe osteoporosis: Preliminary data from Northern Italy
    Massarotti, M.
    Gandolini, G.
    Bevilacqua, M.
    Longhi, M.
    Pietrogrande, L.
    Santi, I.
    BONE, 2009, 44 (02) : S436 - S437
12345